Dermatologikum Hamburg

Hospital


Location: Hamburg, Germany (DE) DE

ISNI: 0000000406304953

ROR: https://ror.org/04whsde46

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with regard to compatibility-related Therapeutic Adherence: Safety Results of the PRIME Study (2017) Mrowietz U, Augustin M, Thaci D, Reich K, Kneidl J, Hentschke C, Simang M, et al. Conference contribution Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis with without previous Systemic Therapy for Improvement of Nail Symptoms: NAPSI Results PRIME Study (2017) Thaci D, Reich K, Mrowietz U, Augustin M, Kneidl J, Hentschke C, Simang M, et al. Conference contribution PASI <= 2 corresponds to PASI 90, irrespective of baseline severity: A post-hoc analysis of the PRIME-study (2017) Reich K, Sieder C, Bachhuber T, Melzer N, Sticherling M Conference contribution Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial (2017) Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, Sticherling M, et al. Journal article Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic treatments: results from the randomized controlled PRIME trial (2017) Sticherling M, Mrowietz U, Augustin M, Thaci D, Melzer N, Hentschke C, Kneidl J, et al. Journal article Epidemiological data on airborne contact dermatitis - results of the IVDK (2015) Breuer K, Uter W, Geier J Journal article Contact allergy induced by bisphenol A diglycidyl ether leachables from aluminium tubes for pharmaceutical use (2015) Breuer K, Lipperheide C, Lipke U, Zapf T, Dickel H, Treudler R, Molin S, et al. Journal article Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT) (2014) Paul C, Puig L, Kragballe K, Luger T, Lambert J, Chimenti S, Girolomoni G, et al. Journal article
‹ 1 2 ›